These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3055148)

  • 21. Clonidine, cortisol, panic disorder, and depression.
    Toutoungi M
    Biol Psychiatry; 1990 Apr; 27(7):802-4. PubMed ID: 2328272
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
    Jonas JM; Cohon MS
    J Clin Psychiatry; 1993 Oct; 54 Suppl():25-45; discussion 46-8. PubMed ID: 8262888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delineation of anxiety and phobic disorders responsive to monoamine oxidase inhibitors: implications for classification.
    Sheehan DV
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):29-36. PubMed ID: 6429129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New treatments for depression.
    Kent S
    Geriatrics; 1982 Nov; 37(11):149-51. PubMed ID: 6982191
    [No Abstract]   [Full Text] [Related]  

  • 25. An open-label trial of nefazodone in high comorbidity panic disorder.
    DeMartinis NA; Schweizer E; Rickels K
    J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of action in the treatment of anxiety.
    Shelton RC; Brown LL
    J Clin Psychiatry; 2001; 62 Suppl 12():10-5. PubMed ID: 11430613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alprazolam in the treatment of panic attack patients with and without major depression.
    Pyke RE; Kraus M
    J Clin Psychiatry; 1988 Feb; 49(2):66-8. PubMed ID: 3338978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenomenology and severity of major depression and comorbid lifetime anxiety disorders in primary medical care practice.
    Brown C; Schulberg HC; Shear MK
    Anxiety; 1996; 2(5):210-8. PubMed ID: 9160625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anxiety in depression.
    Schwab JJ
    Clin Ther; 1984; 6(4):536-45. PubMed ID: 6467281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Potential value of 5-HT2 receptor antagonists in the treatment of dysthymic disorders].
    Sechter D; Bonin B; Bizouard P
    Encephale; 1992 Dec; 18 Spec No 5():753-4. PubMed ID: 1342678
    [No Abstract]   [Full Text] [Related]  

  • 31. Psychopharmacological investigation of panic disorder by means of lactate infusion.
    Murray JB
    J Gen Psychol; 1987 Jul; 114(3):297-311. PubMed ID: 3612109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Critical study of the clinical actions of 5-HTP].
    Teixeira M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1986; 14(2):104-12. PubMed ID: 2873718
    [No Abstract]   [Full Text] [Related]  

  • 33. Neurotransmitter precursors for the treatment of depression.
    Gelenberg AJ; Gibson CJ; Wojcik JD
    Psychopharmacol Bull; 1982 Jan; 18(1):7-18. PubMed ID: 6124021
    [No Abstract]   [Full Text] [Related]  

  • 34. 5-hydroxytryptophan.
    Altern Med Rev; 1998 Jun; 3(3):224-6. PubMed ID: 9630740
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacological treatment of depression and comorbid anxiety disorders.
    Cassano GB; Michelini S
    Adv Biochem Psychopharmacol; 1995; 49():113-25. PubMed ID: 7653331
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacotherapy of generalized anxiety disorder.
    Davidson JR
    J Clin Psychiatry; 2001; 62 Suppl 11():46-50; discussion 51-2. PubMed ID: 11414551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapy of anxiety and depression.
    Psychopharmacol Bull; 1981 Jul; 17(3):91-103. PubMed ID: 7027298
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
    Zajecka JM
    J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lithium augmentation of clomipramine.
    Feder R
    J Clin Psychiatry; 1988 Nov; 49(11):458. PubMed ID: 3141389
    [No Abstract]   [Full Text] [Related]  

  • 40. A functional-dimensional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine.
    Pöldinger W; Calanchini B; Schwarz W
    Psychopathology; 1991; 24(2):53-81. PubMed ID: 1909444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.